NFKB1 and glioblastoma: Recently, it has been reported that MLK4 dependent-NF-κB activation induced a mesenchymal trans-differentiation and radio-resistance in GBM CSC, assigning to MLK4-NF-κB signaling axis a potential prognostic value useful for GBM with a mesenchymal signature [7, 8].